Kronox Lab Sciences Ltd - Stock Valuation and Financial Performance

BSE: 544187 | NSE: KRONOX | Chemicals | Small Cap

Kronox Lab Sciences Share Price

211.75 1.60 0.76%
as on 13-Dec'24 16:59

DeciZen - make an informed investing decision on Kronox Lab Sciences

Overall Rating
Bole Toh

1. Quality

2. Valuation

Overvalued

3. Price Trend

Kronox Lab Sciences stock performance -

mw4me loader
P/E Ratio (SA):
36.80
Market Cap:
785.7 Cr.
52-wk low:
138
52-wk high:
228.5

Is Kronox Lab Sciences Ltd an attractive stock to invest in?

1. Is Kronox Lab Sciences Ltd a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Kronox Lab Sciences Ltd is a average quality company.

2. Is Kronox Lab Sciences Ltd undervalued or overvalued?

The key valuation ratios of Kronox Lab Sciences Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

3. Is Kronox Lab Sciences Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Strong which suggest that the price of Kronox Lab Sciences Ltd is likely to Rise in the short term. However, please check the rating on Quality and Valuation before investing

10 Year X-Ray of Kronox Lab Sciences:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Kronox Lab Sciences Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good

Value Creation

Value Creation Index Colour Code Guide

Mar'21Mar'22Mar'23Mar'24TTM
ROCE % 50.7%55.3%51.6%51.5%-
Value Creation
Index
2.63.02.72.7-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 62.582.395.689.990
Sales YoY Gr.-31.7%16.2%-6%-
Adj EPS 2.53.44.25.75.8
YoY Gr.-39.4%23.6%34.7%-
BVPS (₹) 6.910.312.117.920.8
Adj Net
Profit
9.613.415.721.221
Cash Flow from Ops. 11.3919.717.4-
Debt/CF from Ops. 00.100-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NANA12.9%-6%
Adj EPS NANA32.4%34.7%
BVPSNANA37.5%48.2%
Share Price - - - -

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'21Mar'22Mar'23Mar'24TTM
Return on
Equity %
35.839.93738.229.8
Op. Profit
Mgn %
23.72422.731.533
Net Profit
Mgn %
15.416.316.523.623.7
Debt to
Equity
00000
Working Cap
Days
015114615792
Cash Conv.
Cycle
069706877

Recent Performance Summary

Sales growth is growing at healthy rate in last 3 years 12.89%

Net Profit is growing at healthy rate in last 3 years 32.40%

Return on Equity has declined versus last 3 years average to 29.70%

Sales growth is not so good in last 4 quarters at 4.65%

Latest Financials - Kronox Lab Sciences Ltd.

Standalone Consolidated
TTM EPS (₹) 5.8 -
TTM Sales (₹ Cr.) 89.9 -
BVPS (₹.) 20.8 -
Reserves (₹ Cr.) 40 -
P/BV 10.18 -
PE 36.80 -
From the Market
52 Week Low / High (₹) 138.00 / 228.45
All Time Low / High (₹) 138.00 / 228.45
Market Cap (₹ Cr.) 786
Equity (₹ Cr.) 37.1
Face Value (₹) 10
Industry PE 59.4

Management X-Ray of Kronox Lab Sciences:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Kronox Lab Sciences

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'21Mar'22Mar'23Mar'24
Sales62829690
Operating Expenses 48637462
Manufacturing Costs4456
Material Costs34475546
Employee Cost 1223
Other Costs 79127
Operating Profit 15202228
Operating Profit Margin (%) 23.7%23.9%22.7%31.5%
Other Income 1122
Interest 0000
Depreciation 2211
Exceptional Items 0000
Profit Before Tax 13182229
Tax 3567
Profit After Tax 10141621
PAT Margin (%) 15.6%16.6%17.2%23.8%
Adjusted EPS (₹)2.53.54.45.8
Dividend Payout Ratio (%)0%0%0%9%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'21Mar'22Mar'23Mar'24

Equity and Liabilities

Shareholders Fund 27404566
Share Capital 003737
Reserves 2740829
Minority Interest0000
Debt0000
Long Term Debt0000
Short Term Debt0000
Trade Payables71286
Others Liabilities 4411
Total Liabilities 37565474

Fixed Assets

Gross Block18222637
Accumulated Depreciation9101011
Net Fixed Assets9111626
CWIP 0000
Investments 0000
Inventories5899
Trade Receivables15261918
Cash Equivalents 2344
Others Assets59616
Total Assets 37565474

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'21Mar'22Mar'23Mar'24
Cash Flow From Operating Activity 1192017
PBT 13182229
Adjustment 2211
Changes in Working Capital -1-72-4
Tax Paid -4-5-6-7
Cash Flow From Investing Activity -3-8-7-17
Capex -2-4-8-12
Net Investments -2-40-6
Others 0011
Cash Flow From Financing Activity -7-1-130
Net Proceeds from Shares 0000
Net Proceeds from Borrowing 0000
Interest Paid 0000
Dividend Paid 0000
Others -70-130
Net Cash Flow 1100
PARTICULARSMar'21Mar'22Mar'23Mar'24
Ratios
ROE (%)36.2940.5838.5538.45
ROCE (%)50.7155.3251.6351.52
Asset Turnover Ratio1.671.751.741.41
PAT to CFO Conversion(x)1.10.641.250.81
Working Capital Days
Receivable Days90928574
Inventory Days32293237
Payable Days70706456

Kronox Lab Sciences Ltd Stock News

Kronox Lab Sciences Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Kronox Lab Sciences on 13-Dec-2024 16:59 is ₹211.8.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 13-Dec-2024 16:59 the market cap of Kronox Lab Sciences stood at ₹785.7.
The latest P/E ratio of Kronox Lab Sciences as of 13-Dec-2024 16:59 is 36.80.
The latest P/B ratio of Kronox Lab Sciences as of 13-Dec-2024 16:59 is 10.18.
The 52-week high of Kronox Lab Sciences is ₹228.4 and the 52-week low is ₹138.0.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Kronox Lab Sciences is ₹89.86 ( Cr.) .

About Kronox Lab Sciences Ltd

The company was incorporated on November 18, 2008 as 'Kronox Lab Sciences Private Limited', a private limited company under the Companies Act, 1956, pursuant to a certificate of incorporation dated November 18, 2008 issued by the Assistant Registrar of Companies, Gujarat, Dadra and Nagar Haveli. Subsequently, the company was converted into a public limited company pursuant to a resolution passed by its shareholders at an extra-ordinary general meeting held on May 25, 2019 and a fresh certificate of incorporation dated June 11, 2019 was issued by the Registrar of Companies, Ahmedabad consequent upon conversion, recording the change in the name of the company to 'Kronox Lab Sciences Limited'.   

The company manufactures High Purity Speciality Fine Chemicals for diversified end user industries. Its High Purity Speciality Fine Chemicals are used mainly as (i) reacting agents and raw material in the manufacturing of Active Pharmaceutical Ingredients (APIs); (ii) excipients in pharmaceutical formulations; (iii) reagents for scientific research and laboratory testing; (iv) ingredients in nutraceuticals formulations; (v) process intermediates and fermenting agents in biotech applications; (vi) ingredients in agrochemical formulations; (vii) ingredients in personal care products; (viii) refining agents in metal refineries; and (ix) ingredients in animal health products, amongst others. Its products are manufactured in accordance with industry standards like IP, BP, EP, JP, USP, FCC, LR, AR, GR and ACS in addition to custom manufacturing specifications, which differ from the industry standards, required by its customers in select cases. It manufactures High Purity Speciality Fine Chemicals of various grades in particle sizes ranging from 10 mesh to 100 mesh. Its focus on product development, diversity in product offerings, meeting quality standards and customer specifications and continuous process improvement has led to repeat orders from its customers over the years.

In addition to the manufacturing of products in accordance with various domestic and international standards, it also undertakes custom manufacturing to achieve high levels of purity, as specified by the client, having different purity levels than the prescribed industry standards. Custom manufacturing requires deep domain knowledge, expertise and understanding of the characteristics of each chemical and its compounds, including decreasing the level of existing impurities and the processes to be deployed to reach the desired level of purity. It has set up an in-house research, development and testing laboratory (RDT Laboratory) to develop new products and test its products against the specified industry standards or customer specifications. Its dedicated RDT Laboratory is located in Unit I with the objective to implement a performance-oriented approach with the help of advanced equipment and systems. Its RDT Laboratory is equipped with the necessary facilities to carry out tests required to develop the products. 

Business area of the company

The company is a bulk manufacturer of high purity fine chemicals, in compliance with Reagent, Pharmacopoeia and various Food Grade standards, for the pharmaceutical, nutraceutical, veterinary, food, chemical analysis and other specialty markets. 

Major events:

  • 2008: Incorporation of the company.
  • 2009: Commencement of manufacturing of High Purity Speciality Fine Chemicals at Unit I.
  • 2010: Commenced export of products.
  • 2011: The company expanded its Unit I for manufacturing of High Purity Speciality Fine Chemicals used in pharmaceutical and nutraceutical industries.
  • 2011: The company started manufacturing High Purity Speciality Fine Chemicals to cater to the solar industries.
  • 2014: Acquisition of land along with factory shed for Unit II.
  • 2014: Receipt of FSSC 22000 certification from ISOQAR, UK for Unit I.
  • 2015: Commencement of manufacturing operations at Unit II.
  • 2015: Obtained FSSAI certification for manufacturing of food grade fine chemicals and ingredients.
  • 2017: Receipt of ISO 14001: 2015 & OHSAS 18001:2007 certification in respect of Unit I.
  • 2019: Started manufacturing of products at its Unit III.
  • 2022: Acquisition of land along with factory shed for Unit I and Unit III.
  • 2023: Acquisition of land for proposed Unit IV.


Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.